Copyright
©2014 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Apr 15, 2014; 6(4): 83-97
Published online Apr 15, 2014. doi: 10.4251/wjgo.v6.i4.83
Published online Apr 15, 2014. doi: 10.4251/wjgo.v6.i4.83
MiRNA | AA? | Ref. |
Upregulated in primary CRC | ||
miR-7 | [81] | |
miR-15b | √ | [78,80] |
miR-17-5p | √ | [80] |
miR-17-3p | [76,81] | |
miR-18a | √ | [78,79] |
miR-19a | [78] | |
miR-19b | [78] | |
miR-20a | [79,81] | |
miR-21 | [79,81,83,87,160-163] | |
miR-29a | [78,79,82] | |
miR-92a | [76,79,81-83] | |
miR-96 | [81] | |
miR-106b | [79] | |
miR-133a | [79] | |
miR-142-3p | √ | [80] |
miR-143 | [79] | |
miR-145 | [79] | |
miR-183 | [81] | |
miR-195 | √ | [80] |
miR-196a | [81] | |
miR-214 | [81] | |
miR-221 | [84] | |
miR-331 | √ | [80] |
miR-335 | [78] | |
miR-532-5p | √ | [80] |
miR-532-3p | √ | [80] |
miR-652 | √ | [80] |
miR-1246 | [164] | |
Upregulated in metastatic CRC | ||
miR-15b | √ | [80] |
miR-29a | [85] | |
miR-139-3p | [80] | |
miR-141 | [86] | |
miR-431 | [80] | |
Downregulated in primary CRC | ||
miR-124 | [81] | |
miR-127-3p | [81] | |
miR-138 | [81] | |
miR-143 | [81] | |
miR-146a | [81] | |
miR-222 | [81] | |
miR-601 | √ | [77] |
miR-760 | √ | [77] |
Test name | Cost | Procedure type | Prep? | Sensitivity | Specificity | Note | Ref. |
gFOBT | $53 | Stool test | Yes1 | 12%2 and 40% | 98% | Hemoccult II | [165] |
iFOBT/FIT | $223 | Stool test | Yes1 | 22%2 and 70% | 95% | [165] | |
Fx. Sigmoidoscopy | $500-$7503 | Invasive | Yes | 95%2 and 95% | 92% | [165] | |
Colonoscopy | $800-$16003 | Invasive | Yes | 95%2 and 98% | 90% | [165,166] | |
DCBE | $250-$5003 | X-ray | Yes | 48%2 | 90% | Not recommended by USPSTF | [166] |
CTC | $400-$8003 | CT-scan | Yes | 59%2 | 96% | Not recommended by USPSTF | [166] |
Blood-based test | |||||||
ColonSentry® | $350 | blood-test | No | 78% | 66% | GeneNews/Enzo Biochem | [66] |
MiRNA (5-gene) | Est. $2504 | blood-test | No | Est. 83%-91% | Est. 70%-95% | ||
LncRNA (1-gene) | $385.005 | blood-test | No | N/A | N/A | ||
DNA methylation | Est. $2504 | blood-test | No | Est. 42%-73% | Est. 42%-73% |
- Citation: Ganepola GA, Nizin J, Rutledge JR, Chang DH. Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J Gastrointest Oncol 2014; 6(4): 83-97
- URL: https://www.wjgnet.com/1948-5204/full/v6/i4/83.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v6.i4.83